Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The American Journal of Geriatric Cardiology
|
July 10, 2007
Outcomes of unexplained syncope in the elderly
Oleg Roussanov, Greta Estacio, Maribeth Capuno, et al.
American Heart Journal
|
October 31, 2006
Nonemergent percutaneous coronary interventions in a veterans affairs medical center without onsite cardiac surgery
Oleg Roussanov, Greta Estacio, Maribeth Capuno, et al.
Frontiers in Psychology
|
February 15, 2021
Planting the Seeds: Orchestral Music Education as a Context for Fostering Growth Mindsets
Steven J Holochwost, Judith Hill Bose, Elizabeth Stuk, et al.
The Journal of Invasive Cardiology
|
August 23, 2007
Cost-effectiveness of the radial versus femoral artery approach to diagnostic cardiac catheterization
Oleg Roussanov, S Jeanne Wilson, Katherine Henley, et al.
Infection Control and Hospital Epidemiology
|
June 15, 2007
Methicillin-resistant Staphylococcus aureus infection and colonization among hospitalized prisoners
Marc-Oliver Wright, Jon P Furuno, Richard A Venezia, et al.
Human Vaccines & Immunotherapeutics
|
November 6, 2025
Immune persistence and safety of the AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial
Murdo Ferguson, Tino F Schwarz, Sebastián A Núñez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 27, 2026
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years
Essack Mitha, Murdo Ferguson, Agatha Cathrine Wilhase, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 5, 2024
Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age
Murdo Ferguson, Tino F Schwarz, Sebastián A Núñez, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The American Journal of Geriatric Cardiology
|
July 10, 2007
Outcomes of unexplained syncope in the elderly
Oleg Roussanov, Greta Estacio, Maribeth Capuno, et al.
American Heart Journal
|
October 31, 2006
Nonemergent percutaneous coronary interventions in a veterans affairs medical center without onsite cardiac surgery
Oleg Roussanov, Greta Estacio, Maribeth Capuno, et al.
Frontiers in Psychology
|
February 15, 2021
Planting the Seeds: Orchestral Music Education as a Context for Fostering Growth Mindsets
Steven J Holochwost, Judith Hill Bose, Elizabeth Stuk, et al.
The Journal of Invasive Cardiology
|
August 23, 2007
Cost-effectiveness of the radial versus femoral artery approach to diagnostic cardiac catheterization
Oleg Roussanov, S Jeanne Wilson, Katherine Henley, et al.
Infection Control and Hospital Epidemiology
|
June 15, 2007
Methicillin-resistant Staphylococcus aureus infection and colonization among hospitalized prisoners
Marc-Oliver Wright, Jon P Furuno, Richard A Venezia, et al.
Human Vaccines & Immunotherapeutics
|
November 6, 2025
Immune persistence and safety of the AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial
Murdo Ferguson, Tino F Schwarz, Sebastián A Núñez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 27, 2026
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years
Essack Mitha, Murdo Ferguson, Agatha Cathrine Wilhase, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 5, 2024
Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age
Murdo Ferguson, Tino F Schwarz, Sebastián A Núñez, et al.
Page
of 1